Amidst the ongoing ruckus related to Covid vaccines, Misa Bharti, daughter of Rashtriya Janata Dal supremo Lalu Prasad and Grand Alliance candidate from Patliputra Lok Sabha constituency has given a statement regarding the removal of the photo of Prime Minister Narendra Modi from the Coro
Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first."
An AstraZeneca spokesperson stated, "Our sympathy goes out to anyone who has lost loved ones or reported health problems. Patient safety is our highest priority, and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines."
Medical expert Dr MV Padma Srivastava said that there are rare cases of side effects from vaccines adding that the occurring percentage of the side effects is "very low."
This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, cause TTS."
Vice President Jagdeep Dhankhar on Friday visited Bharat Biotech's facilities at Genome Valley, Hyderabad, which focused on innovation, research and development, and large-scale manufacturing facilities for vaccines.
New Delhi [India], April 5: CliniExperts - India's leading research-to-regulation group has recently joined hands with Manipal Academy of Higher Education (MAHE) to offer comprehensive clinical research and regulatory services to the healthcare, MedTech and Pharmaceutical industry. This part
This collaboration, announced today, aims to bolster the production and supply security of Oral Polio Vaccines (OPV), a crucial step towards achieving a polio-free world.
PM Modi, when Gates asked about how the PM managed the communication with the people during the pandemic that rumours regarding vaccines were controlled here in India unlike other parts of the world, said that he himself used to set examples in front of people.
The Indian Institute of Technology Guwahati successfully transferred a pioneering vaccine technology to BioMed Pvt. Ltd., a lmanufacturing company specialising in high-quality vaccines, on Tuesday. This technology entails a recombinant vector vaccine designed to combat the classical swine fe